Download the BioTrinity 2015 Preliminary Programme here

BioTrinity 2015 - European Biopartnering and Investment Conference - May 11-13, 2015

Where Great MindsSmart Money and Key Dealmakers Meet

BioTrinity™ is the leading European Biopartnering and Investment Conference.  It provides the best opportunity to meet investors, senior licensing executives from global pharma organisations and senior management of innovative drug development and platform technology companies, many of whom present in the company showcase tracks.

Now in its 9th year, over 130 investor delegates from more than 100 firms are expected to attend BioTrinity 2015 from active VC and Corporate Venture firms including J&J, AbbVie, Astellas Venture Management, SR One, Baxter Ventures, Mitsui & Co, Norgine Ventures, MRL Ventures, Merieux Developpement, MS Ventures, Takeda Ventures, Boehringer Ingelheim Ventures, as well as Sofinnova, Abingworth, EdRIP, Lundbeckfond Ventures, Novo A/S, Syncona, Index, Advent, LSP, NeoMed, Fountain, Gilde, Fidelity, Woodford Investment Management and many other international VCs.

This year senior licensing and corporate venture executives from large and mid-sized corporates attending BioTrinity 2015 include AbbVie, Astellas, Actelion, Amgen, AstraZeneca, Baxter, Boehringer, BMS, BTG, GSK, Ferrer, J&J, Lilly, Menarini, MSD, Norgine, Novartis, Novo Nordisk, Mundipharma, Owen Mumford, Philips, Roche, Shire, Takeda, Teijin and UCB. See who else is attending.

At the heart of the event are the world class speaker programme, compelling panels of experts and the powerhouse partnering system.  Together with the unequalled networking opportunities for emerging companies to pitch for partners and investment, BioTrinity has become the best catalyst for business for R&D, pharma and medtech corporates:

  • Network with upto 1,000 delegates from 34 countries including 130 investor delegates
  • Gain insight into securing investment from the smartest money in global life sciences
  • Be inspired by pharma's hottest dealmakers offering fresh perspectives
  • Take your pick of 100 of Europe's best R&D Company Showcases
  • Gain invaluable up-to-date knowledge and insight in your choice of 12 workshops
  • Select who you want to meet in one-to-one meetings through partneringONE®

In 2014 we hosted 2,462 one-to-one meetings over two days between 1,014 delegates from 32 countries, representing more than 624 companies.

Thanks to EBD Group's partneringONE®, the industry gold-standard partnering system with entirely private partnering: 


You need to upgrade your Flash Player

The "Event of the Year" - BioTrinity 2014:

Huge partnering potential with global pharma / investors

 100 presentations by hand-picked R&D companies

 Innovative "Connect for Growth" zones that encouraged informal and formal collaborative interactions

Great networking opportunities with 1000 delegates

 First class venue at Novotel London West

Exciting Social Programme:

 The Big London Networking Party, BioTrinity Welcome Reception and Connect for Drinks

 Europe's Largest Investor-only Dinner

Check out the glowing testimonials we received for BioTrinity, or view the photos from the Gallery

BioTrinity 2014 highlights
1,014 delegates from 32 countries
624 companies
184 speakers
107 company showcase presentations
2,462 one-to-one meetings
130+ investor delegates from 12 countries
61 exhibitors
86 global pharma/medtech delegates
33 corporate venture delegates